Home
>
National Drug Code (NDC)
>
LEUSTATIN
LEUSTATIN - 59676-201-01 - (cladribine)
Drug Information of LEUSTATIN
| Product NDC: | 59676-201 |
| Proprietary Name: | LEUSTATIN |
| Non Proprietary Name: | cladribine |
| Active Ingredient(s): | 1 mg/mL & nbsp; cladribine |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of LEUSTATIN
| Product NDC: | 59676-201 |
| Labeler Name: | Janssen Products, L.P. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020229 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19930301 |
Package Information of LEUSTATIN
| Package NDC: | 59676-201-01 |
| Package Description: | 7 VIAL, SINGLE-USE in 1 CASE (59676-201-01) > 10 mL in 1 VIAL, SINGLE-USE |
NDC Information of LEUSTATIN
| NDC Code | 59676-201-01 |
| Proprietary Name | LEUSTATIN |
| Package Description | 7 VIAL, SINGLE-USE in 1 CASE (59676-201-01) > 10 mL in 1 VIAL, SINGLE-USE |
| Product NDC | 59676-201 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | cladribine |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 19930301 |
| Marketing Category Name | NDA |
| Labeler Name | Janssen Products, L.P. |
| Substance Name | CLADRIBINE |
| Strength Number | 1 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Purine Antimetabolite [EPC] |
